Schrodinger, Inc. EPS - Earnings per Share 2019-2024 | SDGR
Schrodinger, Inc. eps - earnings per share from 2019 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Schrodinger, Inc. Annual EPS | |
|---|---|
| 2023 | $0.54 |
| 2022 | $-2.10 |
| 2021 | $-1.42 |
| 2020 | $-0.41 |
| 2019 | $-4.09 |
| 2018 | $-4.93 |
| Schrodinger, Inc. Quarterly EPS | |
|---|---|
| 2024-09-30 | $-0.52 |
| 2024-06-30 | $-0.74 |
| 2024-03-31 | $-0.76 |
| 2023-12-31 | $-0.41 |
| 2023-09-30 | $-0.86 |
| 2023-06-30 | $0.06 |
| 2023-03-31 | $1.75 |
| 2022-12-31 | $-0.39 |
| 2022-09-30 | $-0.56 |
| 2022-06-30 | $-0.67 |
| 2022-03-31 | $-0.48 |
| 2021-12-31 | $-0.44 |
| 2021-09-30 | $-0.49 |
| 2021-06-30 | $-0.49 |
| 2021-03-31 | $0.00 |
| 2020-12-31 | $-0.07 |
| 2020-09-30 | $0.05 |
| 2020-06-30 | $-0.05 |
| 2020-03-31 | $-0.34 |
| 2019-12-31 | $-2.84 |
| 2019-09-30 | $-0.26 |
| 2019-06-30 | $-0.01 |
| 2019-03-31 | $-0.98 |
| 2018-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||